BAVARIAN NORDIC WKN: 917165 ISIN: DK0015998017 Kürzel: 0DPB Forum: Aktien Thema: Hauptdiskussion
24,53
EUR
-0,57 % -0,14
12:24:47 Uhr,
L&S Exchange
Kommentare 9.151
Bayer1985,
22.05.2022 15:16 Uhr
0
Ich werde eine Mini Position setzen. Der mediale Hype ist noch nicht da. Sollten die Berichterstattungen zunehmen, wird's auch hier noch etwas hochgehen. So die Theorie.
alexpanda,
22.05.2022 15:32 Uhr
0
Die Aktie wird morgen stark ansteigen, die Nachfrage ist riesig.
luciman,
22.05.2022 16:19 Uhr
0
Biden: U.S. exploring monkeypox vaccines; ‘everybody’ should be concerned
On Wednesday, Bavarian Nordic, the Copenhagen-based company that developed the smallpox vaccine licensed for use against monkeypox in the United States, said the U.S. government had exercised its options under an agreement with the company to “supply a freeze-dried version of JYNNEOS® smallpox vaccine, thus allowing for the first doses of this version to be manufactured and invoiced in 2023 and 2024.”
The order of new doses of the vaccine, which has a longer shelf life, is worth $119 million, Bavarian Nordic said in a news release. Under its agreement with the company, the U.S. Biomedical Advanced Research and Development Authority can still exercise options worth $180 million for about 13 million freeze-dried doses of the smallpox vaccine in the future.
A Health and Human Services spokesperson told Axios that the purchase was not a direct response to the infections but said the doses could be used to treat monkeypox.
Separately, Bavarian Nordic said it had “secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022.” Imvanex, as the Jynneos vaccine is known in Europe, is licensed there only for the treatment of smallpox, but it has been used “off-label” in previous monkeypox incidents.
At least two European countries have moved to stockpile vaccines in a possible effort to get ahead of the spread. British Health Secretary Sajid Javid confirmed Friday that the United Kingdom — where the WHO says 21 to 30 monkeypox infections have been reported — has “procured further doses of vaccines that are effective against Monkeypox.”
https://www.washingtonpost.com/politics/2022/05/22/biden-monkeypox-vaccines-outbreak/
Tokloknok,
22.05.2022 10:55 Uhr
0
https://www.nti.org/news/nti-bio-munich-security-conference-convene-global-leaders-annual-tabletop-exercise-reducing-high-consequence-biological-threats/
Regenschauer,
21.05.2022 22:06 Uhr
0
https://www.zdf.de/nachrichten/panorama/affenpocken-corona-virus-unterschiede-infektion-impfung-100.html
KleinerChef,
21.05.2022 21:38 Uhr
0
Dass wir hier recht schnell 50 € sehen und es einen kleinen Hype gibt, kann ich mir sehr gut vorstellen!
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | BAVARIAN NORDIC Hauptdiskussion | ||
| 2 | Affenpocken MPOX Nano repro WKN: 657710 |
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | DAX Hauptdiskussion | ±0,00 % | |
| 2 | Dax Prognose | ±0,00 % | |
| 3 | RENK (für normale, sachliche Kommunikation!) | -5,34 % | |
| 4 | MDATA | ±0,00 % | |
| 5 | NVIDIA Hauptdiskussion | +1,79 % | |
| 6 | DEUTSCHE TELEKOM Hauptdiskussion | -2,06 % | |
| 7 | Novo Nordisk nach Split | +0,27 % | |
| 8 | Virgin Galactica | +1,54 % | |
| 9 | RHEINMETALL Hauptdiskussion | -2,05 % | |
| 10 | Aktuelles zu Almonty Industries | +3,98 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | RENK (für normale, sachliche Kommunikation!) | -5,42 % | |
| 2 | MDATA | ±0,00 % | |
| 3 | NVIDIA Hauptdiskussion | +1,79 % | |
| 4 | DEUTSCHE TELEKOM Hauptdiskussion | -2,06 % | |
| 5 | Novo Nordisk nach Split | +0,27 % | |
| 6 | EUTELSAT Hauptdiskussion | -8,91 % | |
| 7 | Aktuelles zu Almonty Industries | +3,98 % | |
| 8 | Virgin Galactica | +1,54 % | |
| 9 | RHEINMETALL Hauptdiskussion | -1,74 % | |
| 10 | Battalion | -10,40 % | Alle Diskussionen |